$CLGN News

Last published 11h ago

11h agoCLGNLightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26GlobeNewswireLightSolver to present its Boeing corrosion-simulation work and join Birds of a Feather (BoF) session on analog computing at the supercomputing conference in Chicago
6d agoNASDAQ CLGNLightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)GlobeNewswireGovernment-backed R&D program to advance next-generation LPU hardware and expand the LPU Lab platform Builds on LightSolver’s recent commercial and technical momentum, including the strategic partnership with
1w agoNASDAQ CLGNCollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with LightGlobeNewswireRehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) today announced that its Board of Directors has approved a proposal to change the Company’s name to OptiPhi Computing
1w agoNASDAQ CLGNLightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of Photonic Computing TechnologyGlobeNewswireRehovot, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic computing and
1mo agoCLGNCOLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENTPR NewswireTransaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing DevelopmentREHOVOT, Israel, Oct. 9, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), an innovative
1mo agoCLGNLightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering SimulationsPR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary, LightSolver, has filed a provisional patent application with the U....
1mo agoCLGNCOLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update. Yehiel...
1mo agoCLGNLightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC WorkloadsPR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced the publication of joint research conducted by its subsidiary LightSolver Ltd....
1mo agoCLGNCollPlant Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireCollPlant Biotechnologies Ltd. (NASDAQ: CLGN), today announced the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that...
2mo agoCLGNCollPlant to Host LightSolver Investor Webinar on September 17, 2026PR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic...
2mo agoCLGNCOLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITIONPR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced the appointment of Dr. Ruti Ben Shlomi, Chief Executive Officer and Co-Founder of...
2mo agoCLGNCOLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTORPR NewswireCollPlant Biotechnologies Ltd. (NASDAQ: CLGN) today announced the successful closing of its previously announced acquisition of LightSolver Ltd....
2mo agoCLGNCOLLPLANT ANNOUNCES REVERSE SHARE SPLITPR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten...
2mo agoCLGN BACOLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETSPR NewswireCollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that it has signed a definitive agreement to acquire LightSolver Ltd. ("LightSolver"),...
4mo agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENTPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
5mo agoCLGNCOLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and medical aesthetics company developing innovative technologies and products based on its...
7mo agoCLGNCollPlant Issues Letter to ShareholdersPR NewswireCollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...
7mo agoCLGNCOLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
7mo agoCLGNCollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid RequirementPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...
7mo agoCLGNCollPlant Biotechnologies Launches Redesigned Corporate WebsitePR NewswireCollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...
8mo agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTSPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
8mo agoCLGNCollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal FillerPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...
8mo agoCLGNCollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlexPR NewswireCollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...
8mo agoCLGNCollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss TreatmentsPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...
9mo agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERINGPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
11mo agoCLGNCOLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
11mo agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTSPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCollPlant Expands its rhCollagen Distribution Capabilities in the United States and CanadaPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...
1y agoCLGNCollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of TechnologyPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...
1y agoCLGNFirst-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInkPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...
1y agoCLGNCollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue FillerPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...
1y agoCLGNCollPlant Expands the Distribution of its VergenixSTR Product in EuropePR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and...
1y agoCLGNCollPlant to Present at the 2025 International Conference on BiofabricationPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...
1y agoCLGNCollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment ConferencePR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTSPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial OperationsPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its ...
1y agoCLGNCOLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIESPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTSPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULESPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTSPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety StudiesPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and...
1y agoCLGN SSYSCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and...
1y agoCLGNCollPlant Expands Distribution for its VergenixSTR Product in Europe and AsiaPR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and...
1y agoCLGNCollPlant Biotechnologies Provides a Corporate UpdatePR NewswireCollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and...
1y agoCLGNCollPlant Biotechnologies Ltd. (CLGN) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoCLGN SSYSCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
1y agoCLGNCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPR NewswireCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
2y agoCLGNCollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts